Linda Archambault

Dr. Linda Archambault

University of Connecticut Health Center

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Infection and Immunity
Verified
Journal Article
Closed access
PDF file
ABAudrey C. Bergeron
Audrey C. Bergeron
BSBrittany G. Seman
Brittany G. Seman
JHJohn H. Hammond
John H. Hammond
LALinda Archambault
Linda Archambault
DHDeborah A. Hogan
Deborah A. Hogan
Robert WheelerRobert Wheeler
Robert Wheeler
Polymicrobial infections often include both fungi and bacteria and can complicate patient treatment and resolution of infection. Cross-kingdom interactions among bacteria, fungi, and/or the immune system during infection can enhance or block virulence mechanisms and influence disease progression. The fungus Candida albicans and the bacterium Pseudomonas aeruginosa are coisolated in the context of polymicrobial infection at a variety of sites throughout the body, including mucosal tissues such as the lung. In vitro , C. albicans and P. aeruginosa have a bidirectional and largely antagonistic relationship. Their interactions in vivo remain poorly understood, specifically regarding host responses in mediating infection. In this study, we examine trikingdom interactions using a transparent juvenile zebrafish to model mucosal lung infection and show that C. albicans and P. aeruginosa are synergistically virulent. We find that high C. albicans burden, fungal epithelial invasion, swimbladder edema, and epithelial extrusion events serve as predictive factors for mortality in our infection model. Longitudinal analyses of fungal, bacterial, and immune dynamics during coinfection suggest that enhanced morbidity is associated with exacerbated C. albicans pathogenesis and elevated inflammation. The P. aeruginosa quorum-sensing-deficient Δ lasR mutant also enhances C. albicans pathogenicity in coinfection and induces extrusion of the swimbladder. Together, these observations suggest that C. albicans-P. aeruginosa cross talk in vivo can benefit both organisms to the detriment of the host.

13 December 2018 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
EREmily E. Rosowski
Emily E. Rosowski
BKBenjamin P. Knox
Benjamin P. Knox
LALinda Archambault
Linda Archambault
AHAnna Huttenlocher
Anna Huttenlocher
Nancy KellerNancy Keller
Nancy Keller
JDJ. Muse Davis
J. Muse Davis
The zebrafish has become a widely accepted model host for studies of infectious disease, including fungal infections. The species is genetically tractable, and the larvae are transparent and amenable to prolonged in vivo imaging and small molecule screening. The aim of this review is to provide a thorough introduction into the published studies of fungal infection in the zebrafish and the specific ways in which this model has benefited the field. In doing so, we hope to provide potential new zebrafish researchers with a snapshot of the current toolbox and prior results, while illustrating how the model has been used well and where the unfulfilled potential of this model can be found.

31 August 2021 in mBio
Verified
Journal Article
Open access
MBMartinna Bertolini
Martinna Bertolini
Roberto Vazquez-MunozRoberto Vazquez-Munoz
Roberto Vazquez-Munoz
LALinda Archambault
Linda Archambault
SSS. Shah
S. Shah
JSJoao Gabriel Silva Souza
Joao Gabriel Silva Souza
ADA. Dongari-Bagtzoglou
A. Dongari-Bagtzoglou
By comparing Candida albicans virulence and the mucosal bacterial composition in a mouse oral infection model, we were able to dissect the effects of the host environment (immunosuppression), infection with C. albicans , and local modulating factors (availability of sucrose as a carbon source) on the mucosal bacterial microbiome and its role on fungal virulence. We showed that changes in endogenous microbial communities in response to sucrose can lead to attenuation of fungal disease.

17 February 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
Sherli Koshy-ChenthittayilSherli Koshy-Chenthittayil
Sherli Koshy-Chenthittayil
LALinda Archambault
Linda Archambault
DSDhananjai Senthilkumar
Dhananjai Senthilkumar
RLReinhard Laubenbacher
Reinhard Laubenbacher
PMPedro Mendes
Pedro Mendes
ADAnna Dongari-Bagtzoglou
Anna Dongari-Bagtzoglou
The human microbiome has been a focus of intense study in recent years. Most of the living organisms comprising the microbiome exist in the form of biofilms on mucosal surfaces lining our digestive, respiratory, and genito-urinary tracts. While health-associated microbiota contribute to digestion, provide essential nutrients, and protect us from pathogens, disturbances due to illness or medical interventions contribute to infections, some that can be fatal. Myriad biological processes influence the make-up of the microbiota, for example: growth, division, death, and production of extracellular polymers (EPS), and metabolites. Inter-species interactions include competition, inhibition, and symbiosis. Computational models are becoming widely used to better understand these interactions. Agent-based modeling is a particularly useful computational approach to implement the various complex interactions in microbial communities when appropriately combined with an experimental approach. In these models, each cell is represented as an autonomous agent with its own set of rules, with different rules for each species. In this review, we will discuss innovations in agent-based modeling of biofilms and the microbiota in the past five years from the biological and mathematical perspectives and discuss how agent-based models can be further utilized to enhance our comprehension of the complex world of polymicrobial biofilms and the microbiome.

25 June 2019 in mBio
Verified
Journal Article
Open access
PDF file
LALinda Archambault
Linda Archambault
DTDominika Trzilova
Dominika Trzilova
SGSara Gonia
Sara Gonia
CGCheryl Gale
Cheryl Gale
Robert WheelerRobert Wheeler
Robert Wheeler
In modern medicine, physicians are frequently forced to balance immune suppression against immune stimulation to treat patients such as those undergoing transplants and chemotherapy. More-targeted therapies designed to preserve immunity and prevent opportunistic fungal infection in these patients could be informed by an understanding of how fungi interact with professional and nonprofessional immune cells in mucosal candidiasis. In this study, we intravitally imaged these host-pathogen dynamics duringCandidainfection in a transparent vertebrate model host, the zebrafish. Single-cell imaging revealed an unexpected partitioning of the inflammatory response between phagocytes and epithelial cells. Surprisingly, we found thatin vivocytokine profiles more closely matchin vitroresponses of epithelial cells rather than phagocytes. Furthermore, we identified a disconnect between canonical inflammatory cytokine production and phagocyte recruitment to the site of infection, implicating noncytokine chemoattractants. Our study contributes to a new appreciation for the specialization and cross talk among cell types during mucosal infection.

22 March 2017 in Frontiers in Pediatrics
Verified
Journal Article
Open access
SGSara Gonia
Sara Gonia
LALinda Archambault
Linda Archambault
MSMargaret Shevik
Margaret Shevik
MAMarie Altendahl
Marie Altendahl
EFEmily Fellows
Emily Fellows
CGCheryl A. Gale
Cheryl A. Gale
Candida is a leading cause of late-onset sepsis in premature infants and is thought to invade the host via immature or damaged epithelial barriers. We previously showed that the hyphal form of C. albicans invades and causes damage to premature intestinal epithelial cells (pIECs) whereas the non-hyphal C. parapsilosis, also a fungal pathogen of neonates, has less invasion and damage abilities. In this study, we investigated the potential for C. parapsilosis to modulate pathogenic interactions of C. albicans with the premature intestine. While a mixed infection with two fungal pathogens may be expected to result in additive or synergistic damage to pIECs, we instead found that C. parapsilosis was able to protect pIECs from invasion and damage by C. albicans. C. albicans-induced pIEC damage was reduced to a similar extent by multiple different C. parapsilosis strains, but strains differed in their ability to inhibit C. albicans invasion of pIECs, with the inhibitory activity correlating with their adhesiveness for C. albicans and epithelial cells. C. parapsilosis cell-free culture fractions were also able to significantly reduce C. albicans adhesion and damage to pIECs. Furthermore, co-administration of C. parapsilosis cell-free fractions with C. albicans was associated with decreased infection and mortality in zebrafish. These results indicate that C. parapsilosis is able to reduce invasion, damage, and virulence functions of C. albicans. Additionally, the results with cellular and cell-free fractions of yeast cultures suggest that inhibition of pathogenic interactions between C. albicans and host cells by C. parapsilosis occurs via secreted molecules as well as by physical contact with the C. parapsilosis cell surface. We propose that non-invasive commensals can be used to inhibit virulence features of pathogens and deserve further study as a non-pharmacological strategy to protect the fragile epithelial barriers of premature infants.